Domani Wealth’s Edwards Lifesciences EW Stock Holding History

Domani Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,501	Closed	-$220K	–	124
2020 Q1	$220K	Buy	+3,501	New	+$252K	0.06%	117

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Domani Wealth's EW Position: Q2 2020 in Review

Domani Wealth sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 3,501 shares — an estimated $220K sold.

Domani Wealth first reported a position in EW in Q1 2020 and held it in 1 quarter. The position peaked at $220K in Q1 2020. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

Domani Wealth reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
Domani Wealth sold 3,501 Edwards Lifesciences shares in Q2 2020, an estimated $220K.
Domani Wealth first reported a position in Edwards Lifesciences in Q1 2020 and held it in 1 quarter.
Domani Wealth's Edwards Lifesciences position peaked at $220K in Q1 2020.
1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Domani Wealth's 13F filing for Q2 2020, filed 24 Jul 2020.